Country Industry Forecast-Political and Policy Analysis for the Japanese Healthcare Industry

 


The Japanese healthcare industry is the second largest in the world after the United States, and account for 10.0 percent of the world’s market. The success of this industry has been mainly due to the Japanese Government’s supportive role through favorable polices and funds.The Japanese drug market is opening up for foreign investors with the separation of marketing from manufacturing and an improvement in the drug approval system. The revision of the Pharmaceutical Affair Law has made it easier for foreign nationals to operate in the country.This Country Industry Forecast study provides an in-depth analysis of political and policy issues and their implications and key growth opportunities for the Japanese Healthcare Industry.

Regular Price: USD 450

Special Price USD 315

30% OFF

* Required Fields

Regular Price: USD 450

Special Price USD 315

PAY BY INVOICE

Be the first to review this product

Table of Contents

Country Industry Forecast-Political and Policy Analysis for the Japanese Healthcare Industry, Industry Overview and Healthcare SystemIndustry Overview and Healthcare SystemOverview of Healthcare Industry and Healthcare SystemCountry Industry Forecast-Political and Policy Analysis for the Japanese Healthcare Industry, Political EnvironmentPolitical ScenarioGovernment in JapanCountry Industry Forecast-Political and Policy Analysis for the Japanese Healthcare Industry, Macro Economic PoliciesMacro Economic PoliciesOverview of Macro Economic PoliciesCountry Industry Forecast-Political and Policy Analysis for the Japanese Healthcare Industry, Industry PoliciesPharmaceutical SegmentOverview of Pharmaceutical SegmentBiotechnology SegmentOverview of Biotechnology SegmentClinical Trials SegmentOverview of Clinical Trial SegmentMedical Devices and Equipment SegmentOverview of Medical Devices and Equipment SegmentHealthcare IT SegmentOverview of Healthcare IT SegmentCountry Industry Forecast-Political and Policy Analysis for the Japanese Healthcare Industry, Implication of Policies on the Healthcare Industry and Business Growth OpportunitiesImplications of Policies and Growth OpportunitiesImplications of Policies and Growth Opportunities




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.